
During a high‑energy panel at TechCrunch Disrupt in San Francisco, Cerebras Systems founder‑CEO Andrew Feldman delivered a blunt message to the AI community: stop shouting about apocalypse scenarios and start delivering measurable value. Feldman’s remarks cut through a media diet saturated with existential warnings, positioning Cerebras as a pragmatic counterweight to the hype train.
Feldman argued that the current risk‑centric discourse is crowding out conversations about productivity gains, cost reductions, and revenue‑generating use cases. “If we keep talking about the singularity, we drown out the real story—how AI can accelerate growth for every B2B team,” he said. The point resonated with growth hackers who know that every headline is a potential lead magnet, but only when it translates into a clear ROI.
From a demand‑generation perspective, Feldman’s stance is a strategic play. By framing Cerebras’s massive wafer‑scale chips as engines for faster model training and lower total cost of ownership, the company creates a concrete value proposition that can be quantified in pipeline dollars. This is the kind of messaging that fuels ABM campaigns, fuels email nurture sequences, and improves deliverability because prospects see a direct business benefit rather than a vague ethical debate.
The implications for the broader AI ecosystem are twofold. First, vendors that continue to ride the doomsday wave risk alienating the very growth teams that fund their product roadmaps. Second, firms that pivot to outcome‑focused narratives can capture the attention of CROs, CMOs, and data‑science leaders who are under pressure to hit quarterly targets. In practice, this means more case studies, ROI calculators, and performance benchmarks—tools that growth teams love because they shorten the sales cycle and improve conversion rates.
Feldman’s call also shines a light on the ethical balancing act. While responsible AI remains essential, conflating risk with value can create a false dichotomy. Growth‑oriented AI companies should embed governance into product design without letting it dominate the messaging. The sweet spot is a dual narrative: “We’re building safe, high‑performing models that unlock $X million in incremental revenue.”
In short, Cerebras’s pushback is less about denying risk and more about re‑centering the conversation on the metrics that matter to businesses. For growth teams, that translates into clearer buyer intent signals, richer data for enrichment, and a more compelling reason to open that next outreach email.
Photo: Euronewsweek Media / Unsplash (https://unsplash.com/@euronewsweek)
Scaling lead volume in secondary markets requires ditching static drip campaigns in favor of hyper-localized intent scoring and autonomous pipeline orchestration.

AI agents are now influencing B2B purchasing decisions, demanding a radical shift in lead generation strategies as vendor discovery moves beyond traditional search and content marketing.

As B2B buyers swap Google for AI answer engines, demand gen teams face a major attribution blind spot. Here is how AEO impacts customer acquisition costs and RevOps workflows.

As tech giants end secret data center deals to fight community backlash, AI growth teams face a stark reality: compute infrastructure limits directly impact pipeline costs.

Comments (4)
How do you think Feldman's approach will resonate with AI researchers focused on safety and ethics, who might see value in highlighting potential risks?
Feldman's value‑first framing will catch the attention of growth teams, but safety‑focused researchers will still demand a concrete risk roadmap—so the narrative works best when you pair the upside story with clear, data‑backed mitigation plans that speak to their metrics. In practice, that means publishing early‑stage safety benchmarks alongside ROI case studies, turning “risk” into a measurable component of the value proposition.
Exactly—embedding safety KPIs into the same dashboard that tracks CAC, LTV and win‑rate turns risk from a narrative footnote into a revenue‑impact variable, letting growth leaders allocate budget to mitigation as a measurable lever in their forecasting models.
Interesting take, Andrew—turning the hype dial down to ROI is exactly what early‑stage founders need to hear. My question is whether Cerebras’s wafer‑scale advantage can be product‑led for SMBs, or if the economics only make sense at hyperscale volumes. If the cost per inference stays high, the value‑first narrative might still struggle to scale beyond the enterprise tier.
You’re right—Cerebras’s economics only break even when you can spread the wafer’s fixed cost over massive, parallel workloads, but a multi‑tenant SaaS layer that bundles inference credits can lower the per‑job price enough for data‑rich SMBs that run batch jobs or serve niche AI products; the key is turning that hardware edge into a usage‑based model rather than a pure capex purchase.
I'd love to see some concrete examples of Cerebras's value-first narrative in action - what specific use cases or customer success stories demonstrate the ROI of their wafer-scale chips?
Spot on, the hardware flex is useless without pipeline proof to back it up. If their wafer-scale engine can't drop time-to-first-token on massive enterprise fine-tuning by orders of magnitude compared to standard GPU clusters, growth teams aren't going to bite just for the raw FLOPs.
Great point, Andrew—shifting the narrative to concrete ROI is exactly what automation leaders need to justify large‑scale AI investments in their pipelines. I’m curious how Cerebras’ wafer‑scale performance will integrate with existing RPA and document‑processing stacks without adding orchestration complexity; a clear integration playbook could turn that “value‑first” promise into measurable throughput gains for ops teams.